Screen-detected breast cancer compared to symptomatic presentation: an analysis of surgical treatment and end-points of effective mammographic screening.

作者: Andrew J. Spillane , Catherine W. Kennedy , David J. Gillett , Hugh L. Carmalt , Norman C. Janu

DOI: 10.1046/J.1440-1622.2001.02144.X

关键词:

摘要: Background: Mammographic screening has been shown to reduce mortality from breast cancer and offer more opportunity for conservation surgery (BCS). The minimum standards (or surrogate end-points) that need be achieved by a programme if it is have derived the Two County Study. Three end-points can used gauge quality of service are 50% identified infiltrating cancers should < 15 mm; at least 30% grade 3 70% screen-detected negative axillary dissection. present study assesses these effective in an urban population referred Strathfield Breast Centre (TSBC). surgical treatment one group women with BreastScreen New South Wales (NSW)-detected (screen group) were compared all other, mostly symptomatic, referrals (symptom group). problems current pattern acceptance mammographic TSBC’s referral area discussed. Methods: A prospective non-randomized was done via analysis database (TSBC). Results: There 224 screen 657 symptom group. mean tumour size 18.1 mm 22.1 significantly small invasive (< mm) (58%) (33%; P 0.001). In there low-grade tumours but 16% (P = 0.009). patients who underwent dissection, significant difference node negativity, being 72% 59% 0.003). 64% had BCS 51% 0.002). Conclusions: These met NSW TSBC despite biases involved which could lessen effectiveness programme. This crudely translated into reduction selection lead time bias taken account evaluation data. greater chance

参考文章(14)
Iraj Zamiri, DIPHTHERIA TODAY The Lancet. ,vol. 295, pp. 1222- 1223 ,(1970) , 10.1016/S0140-6736(70)91802-7
G Fagerberg, A Gad, S W Duffy, L Tabàr, O Gröntoft, N E Day, Update of the Swedish two-county program of mammographic screening for breast cancer Radiologic Clinics of North America. ,vol. 30, pp. 187- 210 ,(1992)
A.L.M. Verbeek, R. Holland, F. Sturmans, J.H.C.L. Hendriks, M. Avunac, N.E. Day, REDUCTION OF BREAST CANCER MORTALITY THROUGH MASS SCREENING WITH MODERN MAMMOGRAPHY: First Results of the Nijmegen Project, 1975 - 1981 The Lancet. ,vol. 323, pp. 1222- 1224 ,(1984) , 10.1016/S0140-6736(84)91703-3
A. de la Rochefordière, F. Campana, J. Fenton, J.R. Vilcoq, A. Fourquet, B. Asselain, S.M. Scholl, P. Pouillart, J.-C. Durand, H. Magdelenat, Age as prognostic factor in premenopausal breast carcinoma. The Lancet. ,vol. 341, pp. 1039- 1043 ,(1993) , 10.1016/0140-6736(93)92407-K
J Kollias, C.A Murphy, C.W Elston, I.O Ellis, J.F.R Robertson, R.W Blamey, The prognosis of small primary breast cancers European Journal of Cancer. ,vol. 35, pp. 908- 912 ,(1999) , 10.1016/S0959-8049(99)00056-8
H.J.A. Collette, J.J. Rombach, N.E. Day, F. De Waard, EVALUATION OF SCREENING FOR BREAST CANCER IN A NON-RANDOMISED STUDY (THE DOM PROJECT) BY MEANS OF A CASE-CONTROL STUDY The Lancet. ,vol. 323, pp. 1224- 1226 ,(1984) , 10.1016/S0140-6736(84)91704-5
I. Andersson, Mammographic screening under age 50: a review. The Breast. ,vol. 9, pp. 125- 129 ,(2000) , 10.1054/BRST.1999.0163
Sam Shapiro, Periodic Breast Cancer Screening in Reducing Mortality From Breast Cancer JAMA: The Journal of the American Medical Association. ,vol. 215, pp. 1777- 1785 ,(1971) , 10.1001/JAMA.1971.03180240027005
Virginia L Ernster, John Barclay, Karla Kerlikowske, Deborah Grady, I Craig Henderson, Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast JAMA: The Journal of the American Medical Association. ,vol. 275, pp. 913- 918 ,(1996) , 10.1001/JAMA.1996.03530360023033
L. Nyström, S. Wall, L.E. Rutqvist, A. Lindgren, M. Lindqvist, S. Rydén, J. Andersson, N. Bjurstam, G. Fagerberg, J. Frisell, L. Tabár, L.-G. Larsson, Breast cancer screening with mammography : overview of Swedish randomised trials The Lancet. ,vol. 341, pp. 973- 978 ,(1993) , 10.1016/0140-6736(93)91067-V